Genome-Wide Analysis of DNA Methylation Differences in Muscle and Fat from Monozygotic Twins Discordant for Type 2 Diabetes-Reference-Cited by-同舟云学术

Genome-Wide Analysis of DNA Methylation Differences in Muscle and Fat from Monozygotic Twins Discordant for Type 2 Diabetes

Published:2012-12-10 Issue:12 Volume:7 Page:e51302
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ribel-Madsen Rasmus,Fraga Mario F.,Jacobsen Stine,Bork-Jensen Jette,Lara Ester,Calvanese Vincenzo,Fernandez Agustin F.,Friedrichsen Martin,Vind Birgitte F.,Højlund Kurt,Beck-Nielsen Henning,Esteller Manel,Vaag Allan,Poulsen Pernille

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Human genetics illuminates the paths to metabolic disease;S O’Rahilly;Nature,2009

2. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus;J Ek;Diabetologia,2001

3. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk;J Dupuis;Nat Genet,2010

4. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes;L Qi;Hum Mol Genet,2010

5. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis;BF Voight;Nat Genet,2010

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA methylation in human diseases;Heliyon;2024-06

2. Deciphering the complex interplay of risk factors in type 2 diabetes mellitus: A comprehensive review;Metabolism Open;2024-06

3. DNA methylation and type 2 diabetes: a systematic review;Clinical Epigenetics;2024-05-16

4. Enhanced resolution profiling in twins reveals differential methylation signatures of type 2 diabetes with links to its complications;eBioMedicine;2024-05

5. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases;Signal Transduction and Targeted Therapy;2024-03-01